Bernstein Sticks with Buy Rating on UNH as Target Price Remains at $512
Bernstein analyst Lance Wilkes has reaffirmed his buy rating for UnitedHealth (UNH.US) and maintained its target price at $512.
This decision is based on the analyst's past performance, which shows a success rate of 58.3% and an average return of 11.4% over the past year, according to TipRanks data.
The information provided by TipRanks should not be considered as investment advice, but rather for informational purposes only.